Literature DB >> 2427748

Bovine herpesvirus 1: strain comparison of polypeptides and identification of a neutralization epitope on the 90-kilodalton hemagglutinin.

P Trépanier, H C Minocha, Y Bastien, F Nadon, C Séguin, G Lussier, M Trudel.   

Abstract

The intracellular and structural polypeptides of the Los Angeles and Cooper 1 reference strains of bovine herpesvirus 1, together with 12 other Canadian field isolates, were analyzed by polyacrylamide gel electrophoresis. Although a few minor differences were noted among some isolates in regard to intracellular viral protein content, analysis of partly purified virus showed strikingly similar polypeptide profiles among 19 proteins with molecular masses of 14 to 145 kilodaltons (kDa). Moreover, a neutralizing monoclonal antibody produced against the Cooper 1 strain also neutralized all of the other 13 strains tested in this study and immunoprecipitated the major 90-kDa glycoprotein. A second monoclonal antibody with a high hemagglutination inhibition titer prevented hemagglutination of other strains tested and also reacted against the 90-kDa glycoprotein by immunoprecipitation, indicating that this glycoprotein is responsible for the hemagglutinating activity of the viral particle and carries an important neutralization epitope.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427748      PMCID: PMC253931     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  12 in total

Review 1.  Infectious bovine rhinotracheitis: a review and update.

Authors:  R F Kahrs
Journal:  J Am Vet Med Assoc       Date:  1977-11-15       Impact factor: 1.936

2.  A comparison of the acid-soluble polypeptides of five herpesviruses.

Authors:  I W Halliburton; M J Freeman
Journal:  J Gen Virol       Date:  1985-10       Impact factor: 3.891

3.  Hemagglutinating activity associated with bovine herpesvirus type 1.

Authors:  P Trépanier; C Séguin; Y Bastien; G Boulay; G Lussier; M Trudel
Journal:  Vet Microbiol       Date:  1985-12       Impact factor: 3.293

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Neutralizing determinants defined by monoclonal antibodies on polypeptides specified by bovine herpesvirus 1.

Authors:  J K Collins; A C Butcher; C A Riegel; V McGrane; C D Blair; Y A Teramoto; S Winston
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

6.  Analysis of bovine herpes virus-type 1 isolates by restriction endonuclease fingerprinting.

Authors:  V Misra; L A Babiuk; C L Darcel
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

7.  Bovid herpesvirus 1 infection of cattle: pathogenesis, latency, consequences of latency.

Authors:  P P Pastoret; E Thiry; B Brochier; G Derboven
Journal:  Ann Rech Vet       Date:  1982

8.  Bovine herpesvirus 1: differentiation of IBR- and IPV-viruses and identification and functional role of their major immunogenic components.

Authors:  J P Gregersen; G Pauli; H Ludwig
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

9.  Proteins Specified by bovine herpesvirus 1 (infectious bovine rhinotracheitis virus).

Authors:  V Misra; R M Blumenthal; L A Babiuk
Journal:  J Virol       Date:  1981-11       Impact factor: 5.103

10.  European isolates of bovine herpesvirus 1: a comparison of restriction endonuclease sites, polypeptides, and reactivity with monoclonal antibodies.

Authors:  A E Metzler; H Matile; U Gassmann; M Engels; R Wyler
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

View more
  2 in total

1.  Anti-idiotypic antibodies to bovine herpesvirus-1 inhibit virus infection in cell cultures.

Authors:  O Y AbdelMagid; D J Orten; W Xue; F Blecha; H C Minocha
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Identification of 108K, 93K, and 42K glycoproteins of bovine herpesvirus-1 by monoclonal antibodies.

Authors:  E Baranowski; J Dubuisson; P P Pastoret; E Thiry
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.